Clinical and pharmacological group: & nbsp

Means for enteral and parenteral nutrition

Included in the formulation
АТХ:

V.06.A.A   Low-calorie dietary mixtures

Pharmacodynamics:Affects the language receptors that perceive the sweet taste.

The drug consists of two amino acid residues - aspartic and phenylalanine. Contained in food proteins. By the degree of sweetening, it exceeds the sucrose 180-200 times, in 1 g contains 4 kcal. Due to the smaller amount required for sweetening, it is 0.4 kcal from the same sugar mass.

Pharmacokinetics:

It is absorbed in the small intestine. Participates in the exchange of amino acids. Gidroliziruetsya in the gastrointestinal tract with the formation of aspartate, methyl alcohol and phenylalanine. Elimination by the kidneys.

Indications:It is used as a sugar substitute for diabetes, obesity, metabolic syndrome.

IV.E10-E14.E11   Non-insulin-dependent diabetes mellitus

IV.E10-E14.E10   Insulin-dependent diabetes mellitus

IV.E65-E68.E66   Obesity

Contraindications:

Phenylketonuria.

Individual intolerance.

Carefully:Children suffering from diabetes.
Pregnancy and lactation:Recommendations for FDA - not defined. Contraindicated in pregnancy. When lactation: penetrates into breast milk, for healthy children (not suffering from phenylketonuria) is not dangerous.
Dosing and Administration:

1-2 tablets (18-36 mg) per 1 cup (200 ml) of boiling water.

The highest daily dose: up to 40 mg.

The highest single dose: 18 mg.

Side effects:

Perhaps the development of paradoxical bulimia.

Allergic reactions.

Overdose:

After exceeding the maximum dose by the volunteers ten times, no violations were observed.

Interaction:

Not described.

Special instructions:

Aspartame does not cause cognitive disorders, including those with individual sensitivity to the drug.

Instructions
Up